Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

368 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
First characterisation of natural radioactivity in building materials manufactured in Albania.
Xhixha G, Ahmeti A, Bezzon GP, Bitri M, Broggini C, Buso GP, Caciolli A, Callegari I, Cfarku F, Colonna T, Fiorentini G, Guastaldi E, Mantovani F, Massa G, Menegazzo R, Mou L, Prifti D, Rossi Alvarez C, Sadiraj Kuqi D, Shyti M, Tushe L, Xhixha Kaçeli M, Zyfi A. Xhixha G, et al. Among authors: massa g. Radiat Prot Dosimetry. 2013 Jul;155(2):217-23. doi: 10.1093/rpd/ncs334. Epub 2013 Jan 11. Radiat Prot Dosimetry. 2013. PMID: 23315825
A new FSA approach for in situ γ ray spectroscopy.
Caciolli A, Baldoncini M, Bezzon GP, Broggini C, Buso GP, Callegari I, Colonna T, Fiorentini G, Guastaldi E, Mantovani F, Massa G, Menegazzo R, Mou L, Alvarez CR, Shyti M, Zanon A, Xhixha G. Caciolli A, et al. Among authors: massa g. Sci Total Environ. 2012 Jan 1;414:639-45. doi: 10.1016/j.scitotenv.2011.10.071. Epub 2011 Dec 2. Sci Total Environ. 2012. PMID: 22137648
Immune-Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer With Uncommon Histology.
Manglaviti S, Brambilla M, Signorelli D, Ferrara R, Lo Russo G, Proto C, Galli G, De Toma A, Occhipinti M, Viscardi G, Beninato T, Zattarin E, Bini M, Lobefaro R, Massa G, Bottiglieri A, Apollonio G, Sottotetti E, Di Mauro RM, Trevisan B, Ganzinelli M, Fabbri A, de Braud FGM, Garassino MC, Prelaj A. Manglaviti S, et al. Among authors: massa g. Clin Lung Cancer. 2022 Jan;23(1):e17-e28. doi: 10.1016/j.cllc.2021.06.013. Epub 2021 Jul 5. Clin Lung Cancer. 2022. PMID: 34334296
Machine Learning Using Real-World and Translational Data to Improve Treatment Selection for NSCLC Patients Treated with Immunotherapy.
Prelaj A, Boeri M, Robuschi A, Ferrara R, Proto C, Lo Russo G, Galli G, De Toma A, Brambilla M, Occhipinti M, Manglaviti S, Beninato T, Bottiglieri A, Massa G, Zattarin E, Gallucci R, Galli EG, Ganzinelli M, Sozzi G, de Braud FGM, Garassino MC, Restelli M, Pedrocchi ALG, Trovo' F. Prelaj A, et al. Among authors: massa g. Cancers (Basel). 2022 Jan 16;14(2):435. doi: 10.3390/cancers14020435. Cancers (Basel). 2022. PMID: 35053597 Free PMC article.
Prognostic role of neutrophil-to-lymphocyte ratio and EPSILoN score in advanced non-small-cell lung cancer patients treated with first-line chemo-immunotherapy.
Zattarin E, Manglaviti S, Apollonio G, Beninato T, Mazzeo L, Massa G, Bottiglieri A, Galli E, De Toma A, Occhipinti M, Brambilla M, Ferrara R, Ganzinelli M, Proto C, Garassino MC, de Braud F, Lo Russo G, Prelaj A. Zattarin E, et al. Among authors: massa g. Future Oncol. 2022 Jul;18(23):2593-2604. doi: 10.2217/fon-2021-1454. Epub 2022 Jun 20. Future Oncol. 2022. PMID: 35722877
Immunotherapy in advanced Non-Small Cell Lung Cancer patients with poor performance status: The role of clinical-pathological variables and inflammatory biomarkers.
Lobefaro R, Viscardi G, Di Liello R, Massa G, Iacovino ML, Sparano F, Della Corte CM, Ferrara R, Signorelli D, Proto C, Prelaj A, Galli G, De Toma A, Brambilla M, Ganzinelli M, Trevisan B, Ciardiello F, De Braud F, Morgillo F, Garassino MC, Lo Russo G. Lobefaro R, et al. Among authors: massa g. Lung Cancer. 2021 Feb;152:165-173. doi: 10.1016/j.lungcan.2020.12.027. Epub 2020 Dec 28. Lung Cancer. 2021. PMID: 33421923
Beyond First-Line Immunotherapy: Potential Therapeutic Strategies Based on Different Pattern Progressions: Oligo and Systemic Progression.
Prelaj A, Pircher CC, Massa G, Martelli V, Corrao G, Lo Russo G, Proto C, Ferrara R, Galli G, De Toma A, Genova C, Jereczek-Fossa BA, Braud F, Garassino MC, Rebuzzi SE. Prelaj A, et al. Among authors: massa g. Cancers (Basel). 2021 Mar 15;13(6):1300. doi: 10.3390/cancers13061300. Cancers (Basel). 2021. PMID: 33803958 Free PMC article. Review.
368 results